Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LPP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
MCM3AP-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C11orf54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLCB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKAA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYEF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC12A8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKD2L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP2K - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLITRK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCL12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on